MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
4.77%
Quick Ratio
2.44%
Debt to Asset Ratio
1444.92%
Unit: Dollar
Assets Breakdown
    • Property and equipment, net
    • Inventories, net
    • Cash and cash equivalents
    • Accounts receivable
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Common stock, 0.001 par value 1,...
    • Others
Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
45,806
69,383
46,947
46,456
Accounts receivable
18,383
39,718
62,610
21,115
Inventories, net
92,806
106,931
109,378
134,228
Prepaid expenses and other current assets
33,297
35,233
54,221
47,774
Total current assets
190,292
251,265
273,156
249,573
Property and equipment, net
146,778
159,721
169,608
175,985
Intangible assets, net
-
-
725,000
725,000
Total assets
337,070
410,986
1,167,764
1,150,558
Accounts payable
698,974
615,990
459,652
568,799
Accounts payable - related parties
257,248
355,747
393,772
332,373
Accrued expenses
386,754
434,370
380,599
405,495
Accrued interest - related party
605,510
567,422
530,511
495,676
Notes payable and loans (including 522,500 in default)
952,615
1,003,206
1,044,827
970,117
Notes payable and loans - related parties
1,030,193
1,029,453
1,028,697
1,027,885
Deferred revenue
56,528
60,227
95,773
125,174
Total current liabilities
3,987,822
4,066,415
3,933,831
3,925,519
Royalty liability
700,000
700,000
700,000
700,000
Notes payable and loans, net of current
182,564
181,825
181,069
179,747
Total liabilities
4,870,386
4,948,240
4,814,900
4,805,266
Common stock, 0.001 par value 1,500,000,000 shares authorized 971,575,183 issued and outstanding as of march 31, 2026 and 969,017,081 as of december 31, 2025
971,575
969,017
961,993
961,156
Series a preferred stock, non-dividend, 2,500 votes per share, 0.001 par value, 50,000,000 authorized issued and outstanding 3,800 shares
4
4
4
4
Additional paid-in capital
31,637,084
31,609,289
31,488,626
31,408,548
Accumulated other comprehensive income
-
0
-
-7,222
Common stock issuable, -0- as of december 31, 2025 and 1,936,000 as of december 31, 2024
-
0
0
0
Accumulated deficit
-37,141,979
-37,115,564
-36,097,759
-36,017,194
Total stockholders' deficit
-4,533,316
-4,537,254
-3,647,136
-3,654,708
Total liabilities and stockholders' deficit
337,070
410,986
1,167,764
1,150,558
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Inventories, net$92,806 Cash and cashequivalents$45,806 Prepaid expenses andother current assets$33,297 Accounts receivable$18,383 Total current assets$190,292 Property and equipment,net$146,778 Total assets$337,070 Accumulated deficit-$37,141,979 Total liabilities andstockholders' deficit$337,070 Total stockholders'deficit-$4,533,316 Additional paid-in capital$31,637,084 Common stock, 0.001 parvalue 1,500,000,000...$971,575 Series a preferredstock, non-dividend,...$4 Total liabilities$4,870,386 Total currentliabilities$3,987,822 Royalty liability$700,000 Notes payable andloans, net of current$182,564 Notes payable andloans - related...$1,030,193 Notes payable andloans (including...$952,615 Accounts payable$698,974 Accrued interest -related party$605,510 Accrued expenses$386,754 Accounts payable -related parties$257,248 Deferred revenue$56,528

BIOREGENX, INC. (BRGX)

BIOREGENX, INC. (BRGX)